Evidence map›Paper›PMID 30003410›Full record

ArticleJournal of molecular modeling2018

Importance of amino acids Leu135 and Tyr236 for the interaction between EhCFIm25 and RNA: a molecular dynamics simulation study.

Juan David Ospina-Villa, Juan García-Contreras, Jorge Luis Rosas-Trigueros, Esther Ramírez-Moreno, César López-Camarillo, Beatriz Zamora-López, Laurence A Marchat, Absalom Zamorano-Carrillo

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Juan David Ospina-VillaPrograma Institucional de Biomedicina Molecular, Programa de Doctorado en Ciencias en Biotecnología, ENMH, Instituto Politécnico Nacional, Guillermo Massieu Helguera 239, Fracc. La Escalera, Ticomán, Del. Gustavo A. Madero, CP 07320, Ciudad de México, Mexico.
Juan García-ContrerasPrograma Institucional de Biomedicina Molecular, Programa de Doctorado en Ciencias en Biotecnología, ENMH, Instituto Politécnico Nacional, Guillermo Massieu Helguera 239, Fracc. La Escalera, Ticomán, Del. Gustavo A. Madero, CP 07320, Ciudad de México, Mexico.
Jorge Luis Rosas-TriguerosLaboratorio Transdisciplinario de Investigación en Sistemas Evolutivos, ESCOM, Instituto Politécnico Nacional, Av. Juan de Dios Bátiz esq. Miguel Othón de Mendizábal, Col. Lindavista, Del. Gustavo A. Madero, CP 07738, Ciudad de México, Mexico.
Esther Ramírez-MorenoPrograma Institucional de Biomedicina Molecular, Programa de Doctorado en Ciencias en Biotecnología, ENMH, Instituto Politécnico Nacional, Guillermo Massieu Helguera 239, Fracc. La Escalera, Ticomán, Del. Gustavo A. Madero, CP 07320, Ciudad de México, Mexico.
César López-CamarilloPosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, San Lorenzo 290, Colonia del Valle, CP 03100, Ciudad de México, Mexico.
Beatriz Zamora-LópezDepartamento de Psiquiatría y Salud Mental, Facultad de Medicina, UNAM, Circuito Interior y Cerro del Agua, CP 04510, Ciudad de México, Mexico.
Laurence A MarchatPrograma Institucional de Biomedicina Molecular, Programa de Doctorado en Ciencias en Biotecnología, ENMH, Instituto Politécnico Nacional, Guillermo Massieu Helguera 239, Fracc. La Escalera, Ticomán, Del. Gustavo A. Madero, CP 07320, Ciudad de México, Mexico.
Absalom Zamorano-CarrilloPrograma Institucional de Biomedicina Molecular, Programa de Doctorado en Ciencias en Biotecnología, ENMH, Instituto Politécnico Nacional, Guillermo Massieu Helguera 239, Fracc. La Escalera, Ticomán, Del. Gustavo A. Madero, CP 07320, Ciudad de México, Mexico. azamorano@ipn.mx.ORCID http://orcid.org/0000-0003-1679-3036

Funding

Conacyt-Mexico 178550Conacyt-México 249554ECOS-France M14S02SIP-IPN-México 20150720SIP-IPN-México 20160801SIP-IPN-México 20170520
6 · The paper itself

Abstract

The CFIm25 subunit of the heterotetrameric cleavage factor Im (CFIm) is a critical factor in the formation of the poly(A) tail at mRNA 3' end, regulating the recruitment of polyadenylation factors, poly(A) site selection, and cleavage/polyadenylation reactions. We previously reported the homologous protein (EhCFIm25) in Entamoeba histolytica, the protozoan causing human amoebiasis, and showed the relevance of conserved Leu135 and Tyr236 residues for RNA binding. We also identified the GUUG sequence as the recognition site of EhCFIm25. To understand the interactions network that allows the EhCFIm25 to maintain its three-dimensional structure and function, here we performed molecular dynamics simulations of wild-type (WT) and mutant proteins, alone or interacting with the GUUG molecule. Our results indicated that in the presence of the GUUG sequence, WT converged more quickly to lower RMSD values in comparison with mutant proteins. However, RMSF values showed that movements of amino acids of WT and EhCFIm25*L135 T were almost identical, interacting or not with the GUUG molecule. Interestingly, EhCFIm25*L135 T, which is the only mutant with a slight RNA binding activity experimentally, presents the same stabilization of bend structures and alpha helices as WT, notably in the C-terminus. Moreover, WT and EhCFIm25*L135 T presented almost the same number of contacts that mainly involve lysine residues interacting with the G4 nucleotide. Overall, our data proposed a clear description of the structural and mechanistic data that govern the RNA binding capacity of EhCFIm25.

Indexed as

Amino Acid SubstitutionBinding SitesCrystallography, X-RayEntamoeba histolyticaLeucineMolecular Dynamics SimulationmRNA Cleavage and Polyadenylation FactorsMutationPoly AProtein BindingProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandProtein Interaction Domains and MotifsProtein MultimerizationProtozoan ProteinsRNA, BacterialLeucinemRNA Cleavage and Polyadenylation FactorsPoly AProtozoan ProteinsRNA, BacterialRNA, MessengerTyrosineCleavage factorEntamoeba histolyticaMolecular dynamicsPolyadenylationProtein-RNA interaction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.